Fingolimod initiation and cardiac safety trial

Trial Profile

Fingolimod initiation and cardiac safety trial

Phase of Trial: Phase III

Latest Information Update: 01 May 2015

At a glance

  • Drugs Fingolimod (Primary)
  • Indications Multiple sclerosis
  • Focus Adverse reactions
  • Acronyms FIRST
  • Sponsors Novartis
  • Most Recent Events

    • 19 Apr 2012 Results were reported in a Novartis media release.
    • 19 Apr 2012 Status changed to completed.
    • 21 Oct 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top